Agid, Y. Parkinson’s disease: Pathophysiology Lancet
337 (1991) 1321–1324.
Tillerson, J.L. and Miller, G.W. Grid performance test to measure behavioral impairment in the MPTP-treated mouse model of Parkinsonism. J. Neurosci. Methods
123 (2003) 189–200.
Oida, Y., Kitaichi, K., Nakayama, H., Ito, Y., Fujimoto, Y., Shimazawa, M., Nagai, H. and Hara, H. Rifampicin attenuates the MPTP induced neurotoxicity in mouse brain. Brain Res.
1082 (2006) 196–204.
Gao, Z.G., Cui, W.Y., Zhang H.T. and Liu, C.G. Effects of nicotine on 1-methyl,4-phenyl 1,2,3,6 tetrahydropyridine induced depression of striatal dopamine content and spontaneous locomotor activity in C57 black mice. Pharmacol. Res.
38 (1998) 101–106.
Sindhu, M.K., Saravanan, K.S. and Mohanakumar K.P. Behavioral differences in a rotenone-induced hemiparkinsonism rat model developed following intranigral or median forebrain bundle infusion. Brain Res.
1051 (2005) 25–34.
Gerlach, M., Riederer, P., Przuntek, H. and Youdim, M.B.H. MPTP mechanisms of neurotoxicity and their implications for Parkinson’s disease. Eur. J. Pharmacol.
208 (1991) 273–286.
Schmidt, N. and Ferger, B. Neurochemical findings in the MPTP model of Parkinson’s disease. J. Neural Transm.
108 (2001) 1263–1282.
Rozas, G., Lopez-Martin, E., Guerra, M.J. and Labanderia-Garcia, J.L. The overall rod performance test in the MPTP-treated moue model of parkinsonism. J. Neurosci. Methods
83 (1998) 165–175.
Muralikrishnan, D., Samantarary, S. and Mohanakumar K.P. D-deprenyl protects nigrostriatal neurons against 1-methyl 4-phenbyl 1,2,3,6-tetrahyropyridine induced dopaminergic neurotoxicity. Synapse
50 (2003) 7–13.
Bhattacharya, S.K., Satyan, K.S., and Ghosal, S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J. Exp. Biol.
35 (1997) 236–239.
Panda, S. and Kar, A. Evidence for free radical scavenging activity of Ashwagandha root powder in mice. Indian J. Physiol. Pharmacol.
41 (1997) 424–426.
Raja Sankar, S., Manivasagam, T., Albert Singh, V., Krishnamurti, A. and Ramanathan, M. Prophylatic efficacy of Withania somnifera against MPTP-induced Parkinson’s disease in mice. J. Cell Tissue Res.
7 (2007) 975–979.
Mohanasundari, M., Srinivasan, M.S., Sethupathy, S. and Sabesan, M. Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice. J. Neurol. Sci.
249 (2006) 140–144.
Fernagut, P.O., Diguet, E., Labattu, B. and Tison, F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods
113 (2002) 123–130.
Glowinski, J. and Iversen, L.L. Regional studies of cateholamines in the rat brain-I. J. Neurochem.
13 (1966) 655–669.
Fraga, C.G., Leibovitz, B.E. and Tappel, A.L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic. Biol. Med.
4 (1988) 155–161.
Kakkar, P., Das, B. and Viswanathan, P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J. Biochem. Biophys.
21 (1984) 130–132.
Sinha, A.K. Colorimetric assay of catalase. Anal. Biochem.
47 (1972) 389–394.
Lowry, O.H., Rosebrough, N.J., Farr A.L. and Randall, R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem.
193 (1951) 265–275.
Shimazu, S., Takahata, K., Tamashiro, A., Yoneda, F., Iida, Y. and Saji, H., Recovery of motor function and dopaminergic parameters in a mouse model of Parkinson’s disease induced by co-administration of 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine and diethyldithiocarbamate. J. Neural Transm.
110 (2003) 871–883.
Hanakawa, T., Katsumi, Y., Fukuyuma, H., Honda, M., Hayashi, T., Kimura, J. and Shibasaki, H. Mechanisms underlying gait disturbance in Parkinson’s disease: a single photon emission computed tomography study. Brain
122 (1999) 1271–1282.
Ahmad, M., Saleem, S., Ahmad, A.S., Ansari, M.A., Yousuf, S., Hoda, M.N. and Islam, F. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Human. Exp. Toxicol.
24 (2005) 137–147.
Dhanasekaran, M., Uthayathas, S., Karuppagounder, S.S., Parameshwaran, K., Suppiramaniam, V., Ebadi, M. and Brown-Borg, H.M. Ebselen effects on MPTP-induced neurotoxicity. Brain Res.
1118 (2006) 251–254.
Dexter, D.T., Carter, C.J., Wells, F.R., Javoy-Agid, F., Agid, Y., Lees, A., Jenner, P. and Marsden, C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson’s disease. J. Neurochem.
52 (1989) 381–389.
Dexter, D.T., Holley, A.E., Flitter, W.D., Slater, T.F., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P. and Marsden, C.D. Increased levels of lipid hydroperoxides in the parkinsonia substania nigra: an HPLC and ESR study. Mov. Disord.
9 (1994) 92–97.
Chiba, K., Trevor, A. and Castagnoli, N. Jr. Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun.
120 (1984) 574–578.
Zang, L.Y. and Misra, H.P. Generation of reactive oxygen species during the monoamine oxidase catalysed oxidation of the neurotoxicant 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine. J. Biol. Chem.
268 (1993) 16504–16512.
Rojas, P. and Rios, C. Increased striatal lipid peroxidation after intracerebroventricular MPP+ administration to mice. Pharmacol Toxicol.
72 (1993) 364–368.
Adams, J.D. Jr., Klaidman, L.K. and Leung A.C. MPP+ and MPDP+ induced oxygen radical formation with mitchondrial enzymes. Free Radic. Biol. Med.
15 (1993) 181–186.
Muralikrishnan, D. and Mohanakumar, K.P. Neuroprtotection by bromocriptine against 1-methy1 4-pheny1 1,2,3,6 tetrahydrophyridine induced neurotoxicity in mice. FASEB J.
12 (1998) 905–912
Rajeswari, A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Eur. Rev. Med. Pharmacol. Sci.
10 (2006) 157–161.
Devi, P.U., Sharada, A.C., Solomon, F.E. and Kamath, M.S. In vivo growth inhibitory effect of Withania somnifera on a transplantable mouse tumor, Sarcoma 180. Indian J. Exp. Biol.
30 (1992) 169–172.
Dhuley, J.N. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J. Ethnopharmacol.
70 (2000) 57–63.
Russo, A., Izzo A.A., Cardile, V., Borrelli, F. and Vanella, A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine
8 (2001) 125–132.
Bhattacharya, S.K., Kumar, A. and Ghosal, S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother. Res.
Andallu, B. and Radhika, B. Hypoglycemic, and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J. Exp. Biol.
38 (2000) 607–609.
Dhuley, J.N. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother. Res.
15 (2001) 524–528.